+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
The Medicines Company - logo

The Medicines Company aims to be a leader in the areas of serious infectious disease care, acute cardiovascular care, and surgery and perioperative care. Its marketed products include Angiomax, an anticoagulant used during coronary angioplasties; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; and Ionsys for the short-term management of acute postoperative pain. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

Fibrinogen Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Fibrinogen Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 89 Pages
  • Global
From
Fibrinogen Concentrates Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Fibrinogen Concentrates Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • May 2023
  • 85 Pages
  • Global
From
Antithrombotic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Antithrombotic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 89 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition - Product Thumbnail Image

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition

  • Report
  • December 2018
  • 74 Pages
  • Global
From
Hirudin Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Hirudin Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Product Type

  • Report
  • May 2021
  • 105 Pages
  • Global
From
Global Human Growth Hormone Market, by Application, by Distribution Channel, by Region, Industry Analysis and Forecast, 2019 - 2025 - Product Thumbnail Image

Global Human Growth Hormone Market, by Application, by Distribution Channel, by Region, Industry Analysis and Forecast, 2019 - 2025

  • Report
  • February 2020
  • 231 Pages
  • Global
From
Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21.) - Pipeline Review, H2 2018 - Product Thumbnail Image

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21.) - Pipeline Review, H2 2018

  • Drug Pipelines
  • October 2018
  • 102 Pages
  • Global
From
Medicines Company (The) (MDCO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Medicines Company (The) (MDCO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2020
  • 82 Pages
From
Loading Indicator